The PREPARE study: benefits of pharmacogenetic testing are unclear - Authors' reply

Affiliations

¹ Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
² Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
³ Department of Pharmacology and Therapeutics, Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
⁴ Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands. Electronic address: h.j.guchelaar@lumc.nl.

Comment

Jesse J Swen et al. Lancet. 2023.

. 2023 Jun 3;401(10391):1851-1852.

doi: 10.1016/S0140-6736(23)00852-8.

¹ Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
² Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, 2300 RC Leiden, Netherlands.
³ Department of Pharmacology and Therapeutics, Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
⁴ Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, 2300 RC Leiden, Netherlands. Electronic address: h.j.guchelaar@lumc.nl.

No abstract available

Comment on

The PREPARE study: benefits of pharmacogenetic testing are unclear.
Curtis D. Curtis D. Lancet. 2023 Jun 3;401(10391):1850-1851. doi: 10.1016/S0140-6736(23)00854-1. Lancet. 2023. PMID: 37270235 No abstract available.
The PREPARE study: benefits of pharmacogenetic testing are unclear.
Rogers A, Mackenzie IS, MacDonald TM, Doney ASF. Rogers A, et al. Lancet. 2023 Jun 3;401(10391):1850. doi: 10.1016/S0140-6736(23)00853-X. Lancet. 2023. PMID: 37270236 No abstract available.
The PREPARE study: benefits of pharmacogenetic testing are unclear.
Van der Linden L. Van der Linden L. Lancet. 2023 Jun 3;401(10391):1851. doi: 10.1016/S0140-6736(23)00855-3. Lancet. 2023. PMID: 37270237 No abstract available.